BMS sets up International Immuno-Oncology Network; partners with academics
Executive Summary
Bristol-Myers Squibb Co. has teamed up with the following academic partners to create the International Immuno-Oncology Network: Clinica Universidad de Navarra, Dana-Farber Cancer Institute, Earle A. Chiles Research Institute, Institut Gustave Roussy, Istituto Nazionale per lo Studio Cura dei Tumori, Johns Hopkins University’s Sidney Kimmel Comprehensive Cancer Center, Memorial Sloan-Kettering Cancer Center, the Royal Marsden Hospital, the Institute of Cancer Research, the Netherlands Cancer Institute, and the University of Chicago.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Immuno-Oncology
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
- Bristol Myers Squibb Company
- Johns Hopkins University
- Memorial Sloan Kettering Cancer Center
- Dana-Farber/Harvard Cancer Center
- Columbia University
- University of Chicago
- Gustave Roussy
- Peter MacCallum Cancer Centre
- Institute of Cancer Research
- The Sidney Kimmel Comprehensive Cancer Center
- Clinica Universidad de Navarra
- Earle A. Chiles Research Institute
- Royal Marsden Hospital
- Istituto Nazionale per lo Studio Cura dei Tumori
- Netherlands Cancer Institute
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice